Literature DB >> 8376939

Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides.

P T Massa1.   

Abstract

The effect of brain-enriched gangliosides on constitutive and cytokine-inducible expression of major histocompatibility complex (MHC) class I and II genes in cultured astrocytes was studied. Before treatment with gangliosides, astrocytes expressed constitutive MHC class I but not class II molecules, however, the expression of both MHC class I and II cell surface molecules on astrocytes was induced to high levels by interferon gamma (IFN-gamma). Constitutive and IFN-gamma-inducible expression of MHC class I and II molecules was suppressed by treatment of astrocytes with exogenous bovine brain gangliosides in a dose-dependent manner. Constitutive and induced MHC class I and II mRNA levels were also suppressed by gangliosides, indicating control through transcriptional mechanisms. This was consistent with the ability of gangliosides to suppress the binding activity of transcription factors, especially NF-kappa B-like binding activity, important for the expression of both MHC class I and II genes. These studies may be important for understanding mechanisms of central nervous system (CNS)-specific regulation of major histocompatibility molecules in neuroectodermal cells and the role of gangliosides in regulating MHC-restricted antiviral and autoimmune responses within the CNS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8376939      PMCID: PMC2191216          DOI: 10.1084/jem.178.4.1357

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  58 in total

1.  The immunopathology of experimental allergic encephalomyelitis (EAE). III. Differential in situ expression of strain 13 Ia on endothelial and inflammatory cells of (strain 2 x strain 13)F1 guinea pigs with EAE.

Authors:  R A Sobel; R B Colvin
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Identification of Ia glycoproteins in rat thymus and purification from rat spleen.

Authors:  W R McMaster; A F Williams
Journal:  Eur J Immunol       Date:  1979-06       Impact factor: 5.532

3.  Expression of Ia antigens on the surface of human oligodendrocytes and astrocytes in culture.

Authors:  S U Kim; G Moretto; D H Shin
Journal:  J Neuroimmunol       Date:  1985-12       Impact factor: 3.478

4.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis.

Authors:  M Fried; D M Crothers
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

5.  Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family.

Authors:  J L Lalanne; F Bregegere; C Delarbre; J P Abastado; G Gachelin; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1982-02-11       Impact factor: 16.971

6.  Expression of Ia antigens by cultured astrocytes treated with gamma-interferon.

Authors:  M R Hirsch; J Wietzerbin; M Pierres; C Goridis
Journal:  Neurosci Lett       Date:  1983-10-31       Impact factor: 3.046

7.  alpha-Cardiac actin is the major sarcomeric isoform expressed in embryonic avian skeletal muscle.

Authors:  B M Paterson; J D Eldridge
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

8.  Gangliosides in cultured neurons.

Authors:  H Dreyfus; J C Louis; S Harth; P Mandel
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

9.  Ia expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured T cell lines in mice.

Authors:  K Sakai; T Tabira; M Endoh; L Steinman
Journal:  Lab Invest       Date:  1986-03       Impact factor: 5.662

10.  Isolation and nucleotide sequence of mouse NCAM cDNA that codes for a Mr 79,000 polypeptide without a membrane-spanning region.

Authors:  D Barthels; M J Santoni; W Wille; C Ruppert; J C Chaix; M R Hirsch; J C Fontecilla-Camps; C Goridis
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

View more
  9 in total

1.  Ganglioside expression in tissues of mice lacking beta2-microglobulin.

Authors:  A Markotić; A Marusić; J Tomac; J Müthing
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2.

Authors:  R Li; D Gage; R McKallip; S Ladisch
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

3.  In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection.

Authors:  J M Redwine; M J Buchmeier; C F Evans
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 4.  The macrophage in HIV-1 infection: from activation to deactivation?

Authors:  Georges Herbein; Audrey Varin
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

5.  Tissue-specific HIV-1 infection: why it matters.

Authors:  Maile Ay Karris; Davey M Smith
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

6.  Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.

Authors:  Venkataraman Sriram; Sungyoo Cho; Ping Li; Patrick W O'Donnell; Claire Dunn; Kyoko Hayakawa; Janice S Blum; Randy R Brutkiewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

7.  Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis.

Authors:  Ludwig Hamo; Stephen A Stohlman; Maya Otto-Duessel; Cornelia C Bergmann
Journal:  Glia       Date:  2007-08-15       Impact factor: 7.452

8.  A transgenic mouse model to assess the interaction of cytotoxic T lymphocytes with virally infected, class I MHC-expressing astrocytes.

Authors:  G F Rall; L Mucke; M Nerenberg; M B Oldstone
Journal:  J Neuroimmunol       Date:  1994-06       Impact factor: 3.478

Review 9.  Immune responses to RNA-virus infections of the CNS.

Authors:  Diane E Griffin
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.